Ian M. Bell,Mark Fraley,Tesfaye Biftu,Cheng Zhu,Anilkumar Nair,Helen Mitchell
申请号：
US14399649
公开号：
US09227972B2
申请日:
2013.05.03
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention is directed to aliphatic spirolactam derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
